Jialei Wang, Hui Yu, Zhihuang Hu, Zhenhua Wu, Fangling Ning, Yi Yao, Gengsheng Yu, Jinliang Kong, Xuemei Zhang, Zhiyong He. "Firmonertinib combined with platinum-based chemotherapy in patients with
                    <i>EGFR</i>
                    -mutant advanced NSCLC following disease progression on first-line third-generation EGFR-TKI.." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco.2026.44.16_suppl.8610